Epidemiologically, polypharmacy is a critical issue because it has broad implications for public health. The widespread use of multiple medications can lead to adverse drug reactions, drug-drug interactions, and increased healthcare costs. Furthermore, polypharmacy is associated with poorer health outcomes, including increased hospitalizations and mortality rates. Understanding the patterns and consequences of polypharmacy helps epidemiologists develop strategies to minimize its negative impacts.
